Skip to main content

Nonprofit · EIN 47-0951915

MARISA FUND INC

Tax-exempt · HAVERSTRAW, NY 10927

Financials

$118K$118K2023$104K$110K2024$148K$137K2025
Revenue Expenses · by fiscal year end
Financials of MARISA FUND INC by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2025990-EZ$148,251$137,440$10,811$14,594–$14,594
December 31, 2024990-EZ$104,022$110,371-$6,349$3,783$0$3,783
December 31, 2023990-EZ$117,528$118,003-$475$10,132$0$10,132
Financial details: 990-EZ for the year ended December 31, 2025

Revenue

Contributions, gifts and grants
$148,251
Program service revenue
$0
Investment income
$0

Expenses

Grants and similar amounts paid
$105,550
Compensation of officers, directors and key employees
$0
Other expenses
$31,890
Program services (functional)
$105,550

Balance sheet and other

Total assets, start of year
$3,783
Total assets, end of year
$14,594
Total liabilities, end of year
–
Net assets, end of year
$14,594
Cash, savings and investments
$14,594
Gross receipts
$148,251

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990-EZ for the year ended December 31, 2025, highest compensation first.

NameTitleHours / weekCompensation
David GoldwasserChairman12$0
Barbara KohnTreasurer1$0
Scott GoldwasserSecretary1$0
Mitchell S Cairo MDDirector1$0
Adam EndickDirector1$0
Samantha EndickDirector1$0
Jonathan FarrellDirector1$0
990-EZ for the year ended December 31, 2024: 7 people
NameTitleHours / weekCompensation
DAVID GOLDWASSERCHAIR12$0
BARBARA KOHNTREASURER1$0
SCOTT GOLDWASSERSECRETARY1$0
MITCHELL S CAIRO MDDIRECTOR1$0
ADAM ENDICKDIRECTOR1$0
SAMANTHA ENDICKDIRECTOR1$0
JONATHAN FARRELLDIRECTOR1$0
990-EZ for the year ended December 31, 2023: 7 people
NameTitleHours / weekCompensation
DAVID GOLDWASSERCHAIR12$0
BARBARA KOHNTREASURER1$0
SCOTT GOLDWASSERSECRETARY1$0
MITCHELL S CAIRO MDDIRECTOR1$0
ADAM ENDICKDIRECTOR1$0
SAMANTHA ENDICKDIRECTOR1$0
JONATHAN FARRELLDIRECTOR1$0

Address and contacts

Address (IRS master file)
3309 LEEWARD DR, HAVERSTRAW, NY 10927-2129
In care of
% DAVID GOLDWASSER
Mailing address (990-N for 2012)
3309 LEEWARD DRIVE, HAVERSTRAW NY 10927
Principal officer (990-N for 2012)
DAVID GOLDWASSER, 14 E HERITAGE DRIVE, NEW CITY NY 10956
Signed the 990-EZ
David Goldwasser, Chairman
Phone
(914) 522-3890
Return prepared by
ANDREW ASGAR CPA PC

Mission

The Marisa Fund Inc. provides funds for pediatric cancer research and financial assistance to cancer patients and their families.

990-EZ for the year ended December 31, 2025

Program accomplishments

  • The Marisa Fund Inc. provides funding to qualified researchorganizations looking for less toxic forms of cancertreatments.
    Expenses $100,000 · grants $100,000
  • The Marisa Fund Inc. provides financial assistance tofamilies with children fighting cancer, including helpwith funeral expenses to those who lose their battle.
    Expenses $5,550 · grants $5,550

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026990-EZ on file
2024December 31, 2024May 15, 2025990-EZ on file
2023December 31, 2023May 15, 2024990-EZ on file

IRS record

EIN
47-0951915
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2005
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$14,594
Income (IRS master file)
$148,251

Filing history

FormYear endedRevenueExpensesAssetsReturn
990-EZDecember 2025$148,251$137,440$14,594XML
990-EZDecember 2024$104,022$110,371$3,783XML
990-EZDecember 2023$117,528$118,003$10,132XML
990-EZDecember 2022–––IRS
990-EZDecember 2021–––IRS
990-EZDecember 2020–––IRS
990-EZDecember 2018–––IRS
990-N for 2012
Officer: DAVID GOLDWASSER
December 31, 2012≤ $50,000 receipts––e-Postcard

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 47-0951915).

Questions about MARISA FUND INC

What is the EIN of MARISA FUND INC?
The employer identification number (EIN) of MARISA FUND INC is 47-0951915.
Is MARISA FUND INC tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2005.
Are donations to MARISA FUND INC tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does MARISA FUND INC file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of MARISA FUND INC due?
The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did MARISA FUND INC last file with the IRS?
The latest return in the IRS public files is the 990-EZ for the year ended December 2025.
Who is the principal officer of MARISA FUND INC?
The 990-N for 2012 names DAVID GOLDWASSER.
Who are the officers and directors of MARISA FUND INC?
The 990-EZ for the year ended December 31, 2025 lists 7 people; 0 received compensation from the organization.
How much revenue does MARISA FUND INC have?
On its 990-EZ for the year ended December 31, 2025 it reported revenue of $148,251, expenses of $137,440 and total assets of $14,594 at year end.

Other nonprofits in HAVERSTRAW

All nonprofits in HAVERSTRAW · New York · Medical research